CNMT study materials
CNMT study resources

Same-Day Stress/Rest Perfusion in a Patient with Caffeine and Theophylline Exposure

CNMT · Put your knowledge to work in context.

All case studies

Same-Day Stress/Rest Perfusion in a Patient with Caffeine and Theophylline Exposure

A 64-year-old man is scheduled for a same-day Tc-99m tetrofosmin stress/rest myocardial perfusion study. He reports drinking two cups of coffee at 05:30. His appointment is 09:00. He also takes extended-release theophylline 300 mg twice daily for COPD; his last dose was 21:00 the previous evening. His resting heart rate is 58 bpm and blood pressure is 138/84. He has a history of asthma as a child but currently uses only theophylline and a rescue albuterol inhaler about twice weekly. The protocol orders regadenoson stress. The technologist must decide whether to proceed, delay, or contact the cardiologist, and must plan the imaging sequence so the study remains interpretable.

1. Identify the pharmacologic conflicts in this case and state what action you would take before any radiopharmaceutical is drawn up.

Read the worked answer

Two methylxanthine exposures are present: caffeine (half-life ~5 h; two cups ~190 mg) and extended-release theophylline (half-life 8-12 h, longer in COPD). Both are nonselective adenosine receptor antagonists and blunt regadenoson's vasodilation, producing a false-negative or blunted stress response. Standard practice is to withhold caffeine for at least 12 h and theophylline for at least 48 h (often 5 half-lives) before adenosine-receptor agonist stress. At 09:00 the caffeine interval is only ~3.5 h and theophylline ~12 h - both inadequate. The correct action is not to proceed with regadenoson now. Contact the ordering cardiologist to discuss options: reschedule the regadenoson study after appropriate washout (and after theophylline is held per prescribing physician), or switch to an exercise or dobutamine stress modality that does not depend on adenosine receptors. Do not draw up regadenoson until the plan is documented. Also flag the childhood asthma history, since regadenoson is relatively contraindicated in active bronchospasm; his current rescue-inhaler use warrants physician review regardless.

2. If the study is converted to a same-day rest/stress sequence using exercise stress instead, explain the ordering of the two acquisitions and the dose constraints that make it work.

Read the worked answer

For same-day Tc-99m tetrofosmin, use a low dose for the first acquisition and a roughly 3x higher dose for the second so the residual first dose does not contaminate the second image. Typical approach: rest first at ~8-10 mCi, image ~45-60 min later, then exercise stress with ~24-30 mCi. The stress acquisition must follow the rest acquisition by enough time that the rest activity has decayed and the stress counts dominate (Tc-99m t1/2 = 6 h; waiting ~2-3 h between doses is standard). Alternatively stress-first protocols use the low dose for stress and high dose for rest, which is preferred when stress is likely to be abnormal because it lets you stop after the stress images if normal. Key constraints: minimum 2-3 h between injections, stress dose ~3x rest dose, and adequate waiting for hepatobiliary/gut clearance before imaging. Because exercise stress does not require adenosine receptors, the caffeine and theophylline exposures become far less critical - but document the exposure and confirm the patient can achieve adequate heart rate (target ~85% of age-predicted maximum; here ~133 bpm).

3. The patient cannot exercise to target and theophylline cannot be safely stopped. What is the most defensible next step, and what quality-control documentation should accompany it?

Read the worked answer

If adenosine-receptor agonists are blocked and exercise is inadequate, dobutamine stress is the appropriate pharmacologic alternative because it acts on beta-1 receptors, not adenosine receptors, and is not antagonized by caffeine or theophylline. Confirm with the cardiologist that dobutamine is acceptable given his history (dobutamine can provoke arrhythmia and ischemia; contraindicated in significant outflow obstruction or unstable arrhythmia). Documentation should include: the caffeine and theophylline doses and times, the decision rationale, the physician who approved the change, and the monitoring plan (continuous ECG, blood pressure every 3 min, heart rate target, crash cart availability). Also note that theophylline can lower the seizure threshold and interact with dobutamine's chronotropic effect, so titrate carefully and stop at target heart rate or symptom onset. If no pharmacologic stress can be safely performed, reschedule rather than produce a non-diagnostic study.